Shares of CSL, Cochlear and Pro Medicus jumped as investors bought the great healthcare comeback, while Bendigo Bank was sent to the naughty corner.

Three months ago, the plunging share prices of CSL and Commonwealth Bank was the talk of the market. How times have changed.

In vielen Städten in Deutschland und in Europa ist das Konzept der 15-Minuten-Stadt schon Realität. Warum vor allem Frauen ...

US stocks are rallying to the edge of their all-time high after easing oil prices helped calm Wall Street’s worries that inflation could get even worse.

ASX biotechs are in pole position to benefit from the US$66.9 billion ($100bn) that US military and civil authorities are ...

Bei der Logitech G203 unseres Vergleichs von Logitech-Mäusen handelt es sich um Gaming-Maus, die mit einer sehr guten ...

Your daily dose of the most actionable uptrends and downtrends on the ASX based on expert technical analysis.

CSL will launch clinical trials of its new Horizon 2 plasma process in 2027, seeking enhanced yields and regulatory approvals. CSL's investment in advanced manufacturing aligns with its broader push ...

July 29 (Reuters) - Australian biotechnology firm CSL (CSL.AX), opens new tab said on Wednesday it would start clinical trials to support regulatory approval for a new ‌manufacturing process aimed at ...

On August 6, Carlisle Companies Incorporated (NYSE:CSL) announced that its Board of Directors approved a 14% increase in its regular quarterly dividend.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...